Morgan Stanley dropped price target and Cantor Fitzgerald reduced price target on Regeneron Pharmaceuticals stock.

The entities involved

• Regeneron Pharmaceuticals →

  American pharmaceutical company

  • Parabilis Medicines debuted on Nasdaq, achieving IPO haul surpassing Moderna's, while its product received FDA fast-track designation. Regeneron also acquired shares.Sat 13:46
• Morgan Stanley →

  U.S. investment bank

  • Bank of America and Morgan Stanley are restricting third-party AI agents amid cybersecurity scares and a declared bank run threat.Sun 13:24
  • Corning saw rating changes and price target adjustments from Morgan Stanley and Truist Financial, alongside increased shareholding by the Czech National Bank.Sun 11:07
• Cantor Fitzgerald →

  American financial services company

  • The event reports that Brooke Rollins serves as Trump's Agriculture Secretary and notes that Lutnick previously ran Cantor Fitzgerald.Sun 14:13
  • Agilysys CEO Ramesh Srinivasan sold significant company shares, with the transaction disclosed via filings with the SEC, concurrent with a rating from Cantor Fitzgerald.Sun 06:06

Related events

• Leerink Partners, Truist Financial, HSBC, and Cantor Fitzgerald raised target prices on various stocks on October 9, 2026.Oct 10
• Cantor Fitzgerald raised price targets and reaffirmed ratings, while TD Cowen adjusted its ratings for Paylocity on August 7, 2026.Aug 7
• Multiple financial institutions, including Goldman Sachs, JPMorgan Chase, and UBS, issued various target price changes on shares.Oct 12
• Cantor Fitzgerald lowered its price target on MARA stock on October 21, 2026.Wed 15:20
• Analyst provides a high price target for Viking Therapeutics stock.Sep 3